|
|
Title | Creator | Date |
26 |
|
Central Retinal Artery Occlusion With Subsequent Central Retinal Vein Occlusion in Biopsy-Proven Giant Cell Arteritis | Zoë R. Williams, MD; Xiaofei Wang, MD, PhD; David A. DiLoreto Jr, MD, PhD | 2016-09 |
27 |
|
Central Trochlear Palsy: Report of Two Patients With Ipsilesional Palsy and Review of the Literature | Seong-Hae Jeong, MD; Sung-Hee Kim, MD; Seung-Han Lee, MD, PhD; Seong-Ho Park, MD, PhD; Hyo-Jung Kim, PhD; Ji-Soo Kim, MD, PhD | 2016-12 |
28 |
|
Chronic Myelogenous Leukemia Relapse Presenting With Central Nervous System Blast Crisis and Bilateral Optic Nerve Infiltration | Joyce N. Mbekeani, MD, FRCS, FRCOphth; Maaly Abdel Fattah, MD, PhD; Randa M. Al Nounou, MD; Wahiba Chebbo, MD; Mohammed Asif Dogar, MD | 2016-03 |
29 |
|
Chronic Progressive External Ophthalmoplegia in the Absence of Ptosis | Robert C. Bucelli, MD, PhD; Michael S. Lee, MD; Collin M. McClelland, MD | 2016-09 |
30 |
|
Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis | Sean M. Gratton, MD; Angela M. Herro, MD; William J. Feuer, MS; Byron L. Lam, MD | 2016-03 |
31 |
|
Cilioretinal Artery Territory Infarction Associated With Papilledema in a Patient With Neurofibromatosis Type 2 | Omar A. Mahroo, PhD, FRCOphth; Moin D. Mohamed, PhD, FRCOphth; Elizabeth M. Graham, FRCOphth; Samantha S. Mann, MD, FRCOphth; Gordon T. Plant, MD, FRCP; Shazia K. Afridi, MRCP, PhD; Christopher J. Hammond, MD, FRCOphth | 2016-03 |
32 |
|
Cobalt-Chromium Metallosis With Normal Electroretinogram | Lola M. Grillo, BA; Huy V. Nguyen, MD; Stephen H. Tsang, MD, PhD; Donald C. Hood, PhD; Jeffrey G. Odel, MD | 2016-12 |
33 |
|
Congenital Tonic Pupils Associated With Congenital Central Hypoventilation Syndrome and Hirschsprung Disease | Viraj J. Mehta, MD, MBA; Joseph J. Ling, BA; Elizabeth G. Martinez, DO; Anvesh C. Reddy, MD; Sean P. Donahue, MD, PhD | 2016-12 |
34 |
|
Delayed Development of Intracranial Hypertension After Discontinuation of Tetracycline Treatment for Acne Vulgaris | Christine Law, MD; Gary L. Yau, MD; Martin ten Hove, MEng, MD, FRCSC | 2016-03 |
35 |
|
Development of Dural Arteriovenous Fistulas After Cerebral Venous Sinus Thrombosis | Jonathan A. Micieli, MD, CM; Sheldon Derkatch, MD; Vitor M. Pereira, MD; Edward A. Margolin, MD | 2016-03 |
36 |
|
Diagnosis of Tensilon-Negative Ocular Myasthenia Gravis By Daily Selfie | Elan L. Guterman, MD; James V. Botelho, AB; Jonathan C. Horton, MD, PhD | 2016-09 |
37 |
|
Diagnostic Algorithm for Patients With Suspected Giant Cell Arteritis Useful, but No Substitute for Thorough Histopathology | Adarsh George, Bmed; Nicole S. Lim, BMed; Neeranjali S. Jain, BMed (Hons); Calum W. K. Chong, BMed; Farshad Abedi, MD, DMed; ScYing Liu, MBBS; Sarah B. Wang, BA (Hons); Matt Govendir, BSc (Hons); Ashish Agar, FRANZCO, PhDIan; C. Francis, FRACS, PhD | 2016-09 |
38 |
|
Diagnostic Algorithm for Patients With Suspected Giant Cell Arteritis' Useful, but No Substitute for Thorough Histopathology: Response | M. Tariq Bhatti, MD; Mays A. El-Dairi, MD; Thomas J. Cummings, MD; Alan D. Proia, MD | 2016-09 |
39 |
|
Diagnostic Algorithm for Patients With Suspected Giant Cell Arteritis: Comment | Sohan S. Hayreh, MD, MS, PhD, DSc, FRCS, FRCOphth (Hon) | 2016-06 |
40 |
|
Diagnostic Algorithm for Suspected Giant Cell Arteritis: Response | M. Tariq Bhatti, MD, Mays A. El-Dairi, MD; Thomas J. Cummings, MD; Alan D. Proia, MD | 2016-06 |
41 |
|
Difficulties in Daily Life Reported by Patients with Homonymous Visual Field Defects: Erratum | Cristian M. Salgado, MD | 2016-09 |
42 |
|
Does Nocturnal Hypotension Play a Causal Role in Nonarteritic Anterior Ischemic Optic Neuropathy? | Dean M. Cestari, MD; Anthony Arnold, MD | 2016-09 |
43 |
|
Does Treatment of Ocular Myasthenia Gravis With Early Immunosuppressive Therapy Prevent Secondarily Generalization and Should It Be Offered to All Such Patients? | Sui H. Wong, MRCP; Gordon T. Plant, FRCP, FRCOphth; Wayne Cornblath, MD | 2016-03 |
44 |
|
Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement? | Helena Felgueiras, MD; Joana Parra, MD; Simão Cruz, MD; Pedro Pereira, MD; Ana F. Santos, MD; Adriana Rua, MD; Dália Meira, MD; Pedro Fonseca, MD; Catarina Pedrosa, MD; João N. Cardoso, MD; Cristina Almeida, MD; Maria Araújo, MD, Ernestina Santos, MD | 2016-09 |
45 |
|
Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial | Kimberly E. Cello, BS; John L. Keltner, MD; Chris A. Johnson, PhD; Michael Wall, MD for the NORDIC Idiopathic Intracranial Hypertension Study Group | 2016-03 |
46 |
|
Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica | Jeffrey L. Bennett, MD, PhD | 2016-09 |
47 |
|
Fixation Switch Diplopia | Stacy L. Pineles, MD | 2016-06 |
48 |
|
Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor Use | Albert S. Li, MD; Howard D. Pomeranz, MD, PhD | 2016-12 |
49 |
|
Giant Cell Arteritis | Courtney E. Francis, MD | 2016-03 |
50 |
|
Giant Cell Arteritis With Arteritic Anterior Ischemic Optic Neuropathy Is Bilateral Until Proven Otherwise | Nandini Singh, BMed; Adarsh George, BMed; Jeremy Tan, BMed, MD; Shaun Y. P. Ewe, MBBS, BMedSci; Ian C. Francis, FRACS, PhD | 2016-12 |